Potential therapeutic targets for Alzheimer’s disease

Author： McKeon-O’Malley C.   Saunders A.J.   Bush A.I.   Tanzi R.E.  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.2, Iss.2, 1998-12, pp. : 157-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The presenilins as potential drug targets in Alzheimer’s disease

By Cupers P.   Annaert W.G.   Strooper B.D.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 413-422

Informa Healthcare

Access to resources Recommend Favorite

Secretases as therapeutic targets in Alzheimer’s disease: patents 2000 – 2004

By Larner AJ  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 10, 2004-10 ,pp. : 1403-1420

Informa Healthcare

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimer’s Disease

By McGeer P.L.  

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease

By  

Current Drug Metabolism, Vol. 18, Iss. 9, 2017-12 ,pp. : 842-852

Bentham Science Publishers

Access to resources Recommend Favorite

Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 17, 2016-07 ,pp. : 1951-1960

Bentham Science Publishers

Access to resources Recommend Favorite